Descripción de la empresa
Healthcare Realty Trust Incorporated operates as a real estate investment trust focused on the ownership and operation of medical outpatient facilities, primarily situated adjacent to leading hospital campuses. The company functions within the Real Estate sector, specifically categorized under the REIT - Healthcare Facilities industry, a designation that signifies its legal structure and operational model are tied to generating income from real property assets rather than traditional business operations. This entity employs 539 individuals to manage its extensive portfolio, which it expands selectively through strategic property acquisitions and development initiatives. With a total market capitalization of $6.00B and annual revenue reaching $1.18B, the company demonstrates a significant scale within the specialized healthcare real estate niche, indicating a substantial asset base that supports its operational footprint across multiple markets.
Salud financiera
The company reported revenue of $1.18B over the trailing twelve months, while recording a net income of $-248,480,992 and an EBITDA of $703.89M, a disparity that reveals a significant cost structure burdened by high operating expenses or non-operating losses that erode bottom-line profitability despite strong cash generation from core operations. The enterprise generated free cash flow of $107.20M, a metric that provides essential financial flexibility for the REIT to service its obligations, fund acquisitions, or return capital, even in the presence of negative net income. Profitability is further contextualized by three distinct margins: a gross margin of 61.8%, an operating margin of 11.7%, and a negative profit margin of -20.8%, illustrating that while the core leasing and management activities are efficient, the final profit calculation is heavily impacted by interest, taxes, depreciation, and amortization. Liquidity and leverage analysis shows the company holds $26.17M in cash against total debt of $4.15B, resulting in a debt-to-equity ratio of 88.77, which characterizes a highly leveraged balance sheet typical for capital-intensive real estate firms but one that requires careful debt management. Short-term liquidity is constrained, as indicated by a current ratio of 0.73, suggesting that current assets are insufficient to cover current liabilities without relying on cash flow generation or refinancing. Return metrics show a return on equity of -5.0% and a return on assets of 0.6%, indicating that management has not yet achieved positive leverage or operational returns that would satisfy equity holders or generate significant asset appreciation during the current period.
Evaluación de valoración
Valuation multiples present a complex picture, with a trailing P/E ratio listed as N/A due to the negative net income and a forward P/E of -168.50, a figure that implies earnings are currently depressed and suggests the market expects a significant earnings trajectory recovery before traditional P/E metrics become meaningful. The price-to-book ratio stands at 1.28, indicating that the market values the company at a 28% premium over its book value, which may reflect the quality of the underlying healthcare assets or expectations of future rent growth. Alternative valuation measures include a price-to-sales ratio of 5.08 and an EV/EBITDA of 14.30, metrics that suggest the company is trading at a moderate multiple relative to its revenue and earnings before interest, taxes, depreciation, and amortization, potentially reflecting the stability of its rental income streams. The stock has exhibited volatility within a specific range, with a 52-week high of $18.97 and a 52-week low of $14.09, placing the current trading environment within the context of these historical bounds. The beta value of 0.79 indicates that the stock's price volatility is approximately 21% lower than the broader market, suggesting a defensive characteristic often found in healthcare-related assets that may offer some stability during periods of market turbulence.
Growth & Income
Growth dynamics are mixed, with revenue growth year-over-year declining by 7.8% and earnings growth year-over-year listed as N/A due to the negative net income, implying that the company is currently in a contractionary phase regarding top-line revenue rather than an expansionary growth phase. The company is a dividend payer with a yield of 6.1% and a payout ratio of 251.5%, a figure that is mathematically unsustainable based on reported net income as the company pays out significantly more than its earnings, relying instead on cash flow and asset appreciation to fund these distributions. Because the earnings growth rate is not applicable due to losses, the traditional comparison of earnings versus revenue growth is not feasible, though the negative revenue growth clearly indicates a contraction in the portfolio's generating capacity. The overall profile presents a high-yield income opportunity supported by strong free cash flow rather than organic earnings growth, creating a scenario where income is prioritized over capital expansion during this specific financial period.